bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Free Report) was the recipient of a large increase in short interest in the month of June. As of June 15th, there was short interest totaling 1,273 shares, an increase of ∞ from the May 31st total of 0 shares. Based on an average daily volume of 488 shares, the short-interest ratio is presently 2.6 days.
bioAffinity Technologies Price Performance
NASDAQ:BIAFW traded down $0.01 during trading hours on Tuesday, hitting $0.13. 6,008 shares of the company’s stock traded hands, compared to its average volume of 2,457. The business’s fifty day simple moving average is $0.21 and its two-hundred day simple moving average is $0.28. bioAffinity Technologies has a 52 week low of $0.05 and a 52 week high of $0.81.
bioAffinity Technologies Company Profile
bioAffinity Technologies, Inc is a clinical-stage medical device company developing an extracorporeal immunoadsorption platform intended to treat Gram-negative sepsis and other severe inflammatory conditions. The company’s technology employs specialized sorbent cartridges designed to selectively bind and remove circulating endotoxins and inflammatory mediators from the bloodstream, with the goal of supporting critical care interventions and improving patient outcomes.
In preclinical studies, bioAffinity’s hemoperfusion devices have demonstrated the ability to capture lipopolysaccharides released by Gram-negative bacteria, leading to reductions in pro-inflammatory cytokines and enhanced survival rates in animal models.
Read More
- Five stocks we like better than bioAffinity Technologies
- The Quantum Bubble Is Real Enough to Take Seriously
- Why Wall Street Still Sees Massive Upside for AeroVironment Stock
- Why AppLovin’s CEO Is Selling While Quantum Insiders Are Buying
- Volkswagen’s 16-Year Low Masks a Massive Margin Engine
Receive News & Ratings for bioAffinity Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
